Literature DB >> 11465696

The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments.

D T Felson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11465696     DOI： 10.1002/1529-0131(200107)44:7<1477::AID-ART267>3.0.CO;2-O

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  14 in total

1.  Key questions concerning paracetamol and NSAIDs for osteoarthritis.

Authors:  P Courtney; M Doherty
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

Review 2.  Acetaminophen for osteoarthritis.

Authors:  T E Towheed; L Maxwell; M G Judd; M Catton; M C Hochberg; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

3.  CORR Insights ®: Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial.

Authors:  David T Felson
Journal:  Clin Orthop Relat Res       Date:  2013-09-07       Impact factor: 4.176

Review 4.  Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Authors:  Ruth Savage
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Diagnosis and treatment of giant cell arteritis.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Michele Bertoni; Carlo Salvarani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Management of chronic pain in the rheumatic diseases with insights for the clinician.

Authors:  Mary-Ann Fitzcharles; Yoram Shir
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-08       Impact factor: 5.346

Review 7.  Osteoarthritis in 2010: New takes on treatment and prevention.

Authors:  David T Felson
Journal:  Nat Rev Rheumatol       Date:  2011-02       Impact factor: 20.543

8.  Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.

Authors:  T Pincus; G Koch; H Lei; B Mangal; T Sokka; R Moskowitz; F Wolfe; A Gibofsky; L Simon; S Zlotnick; J G Fort
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

Review 9.  Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.

Authors:  Michael T Nurmohamed; Vokko P van Halm; Ben A C Dijkmans
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 10.  Joint structure modification in osteoarthritis: development of SMOAD drugs.

Authors:  J F Beary
Journal:  Curr Rheumatol Rep       Date:  2001-12       Impact factor: 4.686
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.